This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Ventricular Tachycardia, Catecholaminergic Polymorphic, 1 (disorder)
Information about Ventricular Tachycardia, Catecholaminergic Polymorphic, 1 (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Ventricular Tachycardia, Catecholaminergic Polymorphic, 1 (disorder)
Most recent studies have shown that Ventricular Tachycardia, Catecholaminergic Polymorphic, 1 (disorder) shares some biological mechanisms with arrhythmogenic-right-ventricular-dysplasia, brugada-syndrome-(disorder), cardiac-arrest, cardiac-arrhythmia, cardiac-death, cardiac-fibrillation, cardiomyopathies, channelopathies, heart-diseases, heart-failure, long-qt-syndrome, malignant-paraganglionic-neoplasm, polymorphic-ventricular-tachycardia, premature-ventricular-contractions, sudden-cardiac-death, sudden-death, syncope, tachycardia-ventricular, ventricular-fibrillation.
Among the many pathways, these few ones have gauged particular interests from scientists studying Ventricular Tachycardia, Catecholaminergic Polymorphic, 1 (disorder), and have been seen in publications frequently: Aging, Cardiac Conduction, Cardiac Muscle Contraction, Cell Cycle, Glycosylation, Hyperphosphorylation, Innervation, Localization, Muscle Contraction, Pathogenesis, Proteolysis, Response To Caffeine, Response To Camp, Skeletal Muscle Contraction, Swimming
Quite a number of genes have been found to play important roles in Ventricular Tachycardia, Catecholaminergic Polymorphic, 1 (disorder), such as CALM1, CASQ2, FKBP1B, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR1, RYR2, SCD, SCN5A, SCTR, SNCG, TRDN. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.